Mark Applebaum, MD, and colleagues have developed a blood test to identify epigenetic signals in circulating tumor DNA that can serve as a biomarker to predict the disease status in patients with osteosarcoma. #npjPrecisionOncology #BoneCancer Evan Neczypor
https://ow.ly/5bUv50YEzoy